The Alzheimer’s Association reports that more 5.8 million Americans are currently living with Alzheimer’s disease. There is no known cure for Alzheimer’s, although there are a few available options for treating symptoms. However, early research studies indicate that hemp-derived CBD products have potential to eventually become part of treatment for Alzheimer’s disease.
What Causes Alzheimer’s Disease?
There is no clear-cut trigger for developing Alzheimer’s. Your DNA and family history often play a significant role.
Environmental and lifestyle factors can exacerbate any genetic risks. High blood pressure, diabetes, heart disease and smoking can all increase chances of developing Alzheimer’s Disease.
A 2014 study in The Journal of Alzheimer’s Disease concludes that “THC could be a potential therapeutic treatment option for Alzheimer’s disease through multiple functions and pathways.” Other findings from the journal in 2016 demonstrate that CBD significantly reduced many common symptoms of Alzheimer’s Disease including aggression, irritability, sleep distress and delusions. Caregivers in the study said they had lower levels of stress when using CBD.
A 2012 research project notes that the cannabinoid system should be “a prime target for Alzheimer’s Disease therapy” because cannabinoids “show anti-inflammatory, neuroprotective and antioxidant properties and have immunosuppressive effects.” However, a 2009 Cochlane Library review finds that there is “no evidence that cannabinoids are effective in the improvement of disturbed behavior in dementia or in the treatment of other symptoms of dementia.”
*FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements have not been evaluated by the FDA and are not intended to diagnose, treat, or cure any disease. Always check with your physician before starting a new dietary supplement program.